Bridgebio Pharma, Inc. · NASDAQ:BBIO

Hassan Fred received 3,990 Bridgebio Pharma, Inc. shares as an award (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Hassan Fred (Director) received 3,990 Bridgebio Pharma, Inc. shares as an award, leaving 29,879 shares. Filed Jun 24, 2026 (Form 4).

Awarded
3,990 shares
Holding after
29,879 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockAward3,99029,879Direct

Source

View original at SEC

Related